Abstract
Background
Despite advances in optimal pharmacologic therapy, patients with heart failure (HF) continue to have significant rehospitalization rates.
Hypothesis
We sought to provide current estimates on rates of readmission for Medicare patients with HF, and identify factors associated with an increased chance of readmission.
Methods
We used Medicare data from the 5% sample Standard Analytical File Limited Data Set for the years 2002 through 2004 to calculate readmission rates for HF. Clinical factors associated with readmission rates were identified using multivariate logistic regression.
Results
We identified 28,919 patients accounting for 38,849 HF hospitalizations in the 5% sample for 2003. These numbers project to an estimated 578,380 patients with 776,980 HF hospitalizations. In‐hospital mortality was 4.4% with an average length of stay of 5.5 ± 5.4 d. In the 6—9 mo following the initial HF admission, 60% of patients had 1 or more readmissions for any cause. Heart failure accounted for 28% of all readmissions. Factors associated with readmission for HF after the initial HF hospitalization included age < 65 y, geographic location, previous hospitalization, length of stay of initial HF hospitalization > 7 d, not receiving a cardiac device implant at the time of initial HF hospitalization, and history of comorbidities including diabetes, myocardial infarction, peripheral vascular disease, and stroke.
Conclusions
Medicare patients with HF continue to have significant morbidity and one of the highest in‐hospital mortality rates of any HF patient population. Factors associated with worse outcomes after an initial HF hospitalization can be used to identify patients who require aggressive therapy and follow‐up. Copyright © 2009 Wiley Periodicals, Inc.
Keywords: heart failure, hospital readmission rates
Full Text
The Full Text of this article is available as a PDF (104.9 KB).
References
- 1. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, et al.; for the American Heart Association Statistics Committee and Stroke Statistics Subcommittee: Heart disease and stroke statistics 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007; 115: e69–e171. [DOI] [PubMed] [Google Scholar]
- 2. MERIT‐HF Study Group: Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT‐HF). Lancet 1999; 353: 2001–2007. [PubMed] [Google Scholar]
- 3. Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, et al.; Carvedilol Prospective Randomized Cumulative Survival Study Group: Effect of carvedilol on survival in severe heart failure. N Engl J Med 2001; 344: 1651–1658. [DOI] [PubMed] [Google Scholar]
- 4. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, et al.; for the Randomized Aldactone Evaluation Study Investigators: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999; 341: 709–717. [DOI] [PubMed] [Google Scholar]
- 5. The CONSENSUS Trial Study Group: Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Survival Study (CONSENSUS). N Engl J Med 1987; 316: 1429–1435. [DOI] [PubMed] [Google Scholar]
- 6. Taylor AL, Ziesche S, Yancy C, Carson P, D'Agostino R Jr, et al.; African‐American Heart Failure Trial Investigators: Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med 2004; 351: 2049–2057. [DOI] [PubMed] [Google Scholar]
- 7. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, et al: ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure), Circulation 2005; 112: e154–e235. [DOI] [PubMed] [Google Scholar]
- 8. Krumholz HM, Parent EM, Tu N, Vaccarino V, Wang Y, et al: Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med 1997; 157: 99–104. [PubMed] [Google Scholar]
- 9. Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, et al: A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995; 333: 1190–1195. [DOI] [PubMed] [Google Scholar]
- 10. Cleland JGF, Daubert JC, Erdmann E, Freemantle N, Gras D, et al.; Cardiac Resynchronization‐Heart Failure (CARE‐HF) Study Investigators: The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 2005; 352: 1539–1549. [DOI] [PubMed] [Google Scholar]
- 11. Krumholz HM, Wang Y, Mattera JA, Wang Y, Han LF, et al: An administrative claims model suitable for profiling hospital performance based on 30‐day mortality rates among patients with heart failure. Circulation 2006; 113: 1693–1701. [DOI] [PubMed] [Google Scholar]
- 12. Fonarow GC, Corday E; ADHERE Scientific Advisory Committee: Overview of acutely decompensated congestive heart failure (ADHF): A report from the ADHERE registry. Heart Fail Rev 2004; 9: 179–185. [DOI] [PubMed] [Google Scholar]
- 13. Cuffe MS, Califf RM, Adams KF Jr, Benza R, Bourge R, et al.; Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME‐CHF) Investigators: Short‐term intravenous milrinone for acute exacerbation of chronic heart failure: A randomized trial. JAMA 2002; 287: 1541–1547. [DOI] [PubMed] [Google Scholar]
- 14. Baker DW, Einstadter D, Thomas C, Cebul RD: Mortality trends for 23,505 Medicare patients hospitalized with heart failure in Northeast Ohio, 1991 to 1997. Am Heart J 2003; 146: 258–264. [DOI] [PubMed] [Google Scholar]
- 15. Kosiborod M, Lichtman JH, Heidenreich PA, Normand SL, Wang Y, et al: National trends in outcomes among elderly patients with heart failure. Am J Med 2006; 119: 616.e1–616.e7. [DOI] [PubMed] [Google Scholar]
- 16. Aranda JM, Krause‐Steinrauf HJ, Greenberg BH, Heng MK, Kosolcharoen PK, et al: Comparison of the beta blocker bucindolol in younger versus older patients with heart failure. Am J Card 2002; 89: 1322–1326. [DOI] [PubMed] [Google Scholar]
- 17. Brown DW, Haldeman GA, Croft JB, Giles WH, Mensah GA: Racial or ethnic differences in hospitalization for heart failure among elderly adults: Medicare, 1990 to 2000. Am Heart J 2005; 150: 448–454. [DOI] [PubMed] [Google Scholar]
- 18. Rathore SS, Foody JM, Wang Y, Smith GL, Herrin J, et al: Race, quality of care, and outcomes of elderly patients hospitalized with heart failure. JAMA 2003; 289: 2517–2524. [DOI] [PubMed] [Google Scholar]